The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Keith Oldroyd
Showing 1-20 of 21 articles
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial
van Geuns R,
Chun-Chin C,
McEntegart M,
Merkulov E,
Kretov E,
Lesiak M,
O’Kane P,
Hanratty C,
Bressollette E,
Silvestri M,
Wlodarczak A,
Barragan P,
Anderson R,
Protopopov A,
Peace A,
Menown I,
Rocchiccioli P,
Onuma Y,
Oldroyd K
April 22, 2022 | 10.4244/EIJ-D-21-00514
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction
Maznyczka A,
Carrick D,
Oldroyd K,
James-Rae G,
McCartney P,
Greenwood J,
Good R,
McEntegart M,
Eteiba H,
Lindsay M,
Cotton J,
Petrie M,
Berry C
June 25, 2021 | 10.4244/EIJ-D-19-00904
Deep learning for prediction of fractional flow reserve from resting coronary pressure curves
Zimmermann F,
Mast T,
Johnson NP,
Everts I,
Hennigan B,
Berry C,
Johnson D,
De Bruyne B,
Fearon W,
Oldroyd K,
Pijls N,
Tonino P,
van 't Veer M
May 16, 2021 | 10.4244/EIJ-D-20-00648
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial
El Farissi M,
Keulards D,
van 't Veer M,
Zelis J,
Berry C,
De Bruyne B,
Engstrøm T,
Fröbert O,
Piróth Z,
Oldroyd K,
Tonino P,
Pijls N,
Otterspoor L
April 20, 2021 | 10.4244/EIJ-D-19-00471
Continuous intracoronary versus standard intravenous infusion of adenosine for fractional flow reserve assessment: the HYPEREMIC trial
Elghamaz A,
Myat A,
de Belder A,
Collison D,
Cocks K,
Stone G,
Oldroyd K
September 18, 2020 | 10.4244/EIJ-D-18-01067
Intravascular lithotripsy to treat a severely underexpanded coronary stent
Watkins S,
Good R,
Hill J,
Brinton TJ,
Oldroyd K
May 20, 2019 | 10.4244/EIJ-D-18-00780
Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve
Matsumura M,
Maehara A,
Johnson NP,
Fearon W,
De Bruyne B,
Oldroyd K,
Pijls N,
Jenkins P,
Ali ZA,
Mintz GS,
Stone G,
Jeremias A
February 7, 2019 | 10.4244/EIJ-D-17-01149
Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study
Svanerud J,
Ahn J,
Jeremias A,
van 't Veer M,
Gore A,
Maehara A,
Crowley A,
Pijls N,
De Bruyne B,
Johnson NP,
Hennigan B,
Watkins S,
Berry C,
Oldroyd K,
Park S,
Ali ZA
September 20, 2018 | 10.4244/EIJ-D-18-00342
Incidence of procedural myocardial infarction and cardiac magnetic resonance imaging-detected myocardial injury following percutaneous coronary intervention with rotational atherectomy
McEntegart M,
Corcoran D,
Carrick D,
Clerfond G,
Sidik N,
Collison D,
Robertson KR,
Shaukat A,
Watkins S,
Rocchicholi PR,
Eteiba H,
Petrie M,
Lindsay M,
Oldroyd K,
Berry C
September 20, 2018 | 10.4244/EIJ-D-17-01077
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study
Walsh S,
Hanratty C,
Watkins S,
Oldroyd K,
Mulvihill N,
Hensey M,
Chase A,
Smith D,
Cruden N,
Spratt J,
Mylotte D,
Johnson TW,
Hill J,
Hussein H,
Bogaerts K,
Morice M,
Foley DP
June 14, 2018 | 10.4244/EIJ-D-18-00346
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco DJ
April 20, 2018 | 10.4244/EIJ-D-17-00529
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Resistance to flow in the coronary microcirculation – we can measure it but what does it mean?
Bajrangee A,
Collison D,
Oldroyd K
October 20, 2017 | 10.4244/EIJV13I8A133
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
Stefanini G,
Behan M,
Valgimigli M,
Oldroyd K,
Leon MB
August 20, 2016 | 10.4244/EIJV12I6A129
Will this trial change my practice? TOTAL: a randomised trial of thrombus aspiration in ST-elevation myocardial infarction
Behan M,
Haude M,
Oldroyd K,
Lansky AJ,
James S,
Baumbach A
July 20, 2015 | 10.4244/EIJV11I3A70
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study
Watkins S,
Oldroyd K,
Preda I,
Holmes D,
Colombo A,
Morice M,
Leadley K,
Dawkins K,
Mohr F,
Serruys P,
Feldman T
April 20, 2015 | 10.4244/EIJV10I12A244
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study
Austin D,
Mackay D,
Morley R,
Christie J,
Hennigan B,
De Belder M,
Pell J,
Oldroyd K
February 20, 2015 | 10.4244/EIJY14M05_11
Fractional flow reserve and the index of microvascular resistance in patients with acute coronary syndromes
Hennigan B,
Layland J,
Fearon W,
Oldroyd K
August 19, 2014 | 10.4244/EIJV10STA10
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)
Routledge H,
Lefèvre T,
Colombo A,
Oldroyd K,
Hamm C,
Guagliumi G,
von Scheidt W,
Guetta V,
Ruzyllo W,
Wittebols K,
Goedhart D,
Serruys P
June 30, 2009
1
2
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023